Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02483728 · ClinicalTrials.gov registry record · NA
Cutaneous and Systemic Reactions to Metal Implants
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02483728 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 6 participants.
The verdict
NCT02483728, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if metal patch testing in metal allergic patients is useful for predicting the development of allergic skin disease or systemic symptoms in patients who recieve a metal orthopedic implant.
Interventions
- OTHER Patch Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02483728
The ClinicalTrials.gov registry entry for NCT02483728 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patch Test is the first listed.
NCT02483728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02483728 about?
NCT02483728 is a clinical study titled "Cutaneous and Systemic Reactions to Metal Implants". The purpose of this study is to evaluate if metal patch testing in metal allergic patients is useful for predicting the development of allergic skin disease or systemic symptoms in patients who recieve a metal orthopedic implant.
What is the current status of trial NCT02483728?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-08. Estimated completion is 2018-06-05.
What interventions are being tested in trial NCT02483728?
The interventions under investigation include: Patch Test (OTHER).
Who is sponsoring clinical trial NCT02483728?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.